Warning letter
Royal Philips: warning letter of Feb 23, 2024
FDA warning letter 676605 · Center for Devices and Radiological Health
Key facts
| Reference number | 676605 |
|---|---|
| Company | Royal Philips |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Feb 23, 2024 |
| Posted date | Apr 23, 2024 |
| Issuing office | Center for Devices and Radiological Health |
| Product type | Devices |
| CFR sections cited | 820, 806, 806.10 |
| Inspection city | Suzhou |
| Inspection start date | Oct 23, 2023 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: